212 related articles for article (PubMed ID: 28247754)
1. Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity.
Chen T; Li C; Li Y; Yi X; Wang R; Lee SM; Zheng Y
ACS Appl Mater Interfaces; 2017 Mar; 9(11):9516-9527. PubMed ID: 28247754
[TBL] [Abstract][Full Text] [Related]
2. Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease.
Chen T; Li C; Li Y; Yi X; Lee SM; Zheng Y
Mol Pharm; 2016 Nov; 13(11):3864-3875. PubMed ID: 27740776
[TBL] [Abstract][Full Text] [Related]
3. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
4. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
5. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
7. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
Katsikogianni G; Avgoustakis K
J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
[TBL] [Abstract][Full Text] [Related]
8. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
9. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
[TBL] [Abstract][Full Text] [Related]
10. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
11. Pluronic P85/F68 Micelles of Baicalein Could Interfere with Mitochondria to Overcome MRP2-Mediated Efflux and Offer Improved Anti-Parkinsonian Activity.
Chen T; Li Y; Li C; Yi X; Wang R; Lee SM; Zheng Y
Mol Pharm; 2017 Oct; 14(10):3331-3342. PubMed ID: 28806519
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease.
Chen T; Liu W; Xiong S; Li D; Fang S; Wu Z; Wang Q; Chen X
ACS Appl Mater Interfaces; 2019 Dec; 11(48):45276-45289. PubMed ID: 31638771
[TBL] [Abstract][Full Text] [Related]
14. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
15. Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson's Disease.
Zhao Y; Xiong S; Liu P; Liu W; Wang Q; Liu Y; Tan H; Chen X; Shi X; Wang Q; Chen T
Int J Nanomedicine; 2020; 15():10453-10467. PubMed ID: 33380795
[TBL] [Abstract][Full Text] [Related]
16. Idarubicin-loaded methoxy poly(ethylene glycol)-
Liang B; Li N; Zhang S; Qi A; Feng J; Jing W; Shi C; Ma Z; Gao S
Int J Nanomedicine; 2019; 14():543-556. PubMed ID: 30666113
[TBL] [Abstract][Full Text] [Related]
17. Novel PLGA-based nanoparticles for the oral delivery of insulin.
Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
[TBL] [Abstract][Full Text] [Related]
18. Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.
Xie B; Liu Y; Guo Y; Zhang E; Pu C; He H; Yin T; Tang X
Pharm Res; 2018 Feb; 35(3):62. PubMed ID: 29445971
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
[No Abstract] [Full Text] [Related]
20. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
